Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) EBITDA (2016 - 2026)

InflaRx's EBITDA history spans 9 years, with the latest figure at -$6.6 million for Q1 2026.

  • On a quarterly basis, EBITDA rose 26.27% to -$6.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$53432.9 billion, a 8.69% decrease, with the full-year FY2025 number at -$53433.0 billion, down 8.69% from a year prior.
  • EBITDA hit -$6.6 million in Q1 2026 for InflaRx, up from -$53432.9 billion in the prior quarter.
  • Over the last five years, EBITDA for IFRX hit a ceiling of $16.4 million in Q2 2025 and a floor of -$53432.9 billion in Q4 2025.
  • Historically, EBITDA has averaged -$9642.2 billion across 5 years, with a median of -$14.1 million in 2022.
  • Biggest five-year swings in EBITDA: plummeted 323805866.21% in 2023 and later soared 100.0% in 2024.
  • Tracing IFRX's EBITDA over 5 years: stood at -$14.1 million in 2022, then plummeted by 323805866.21% to -$45773.1 billion in 2023, then decreased by 7.4% to -$49161.8 billion in 2024, then fell by 8.69% to -$53432.9 billion in 2025, then skyrocketed by 100.0% to -$6.6 million in 2026.
  • Business Quant data shows EBITDA for IFRX at -$6.6 million in Q1 2026, -$53432.9 billion in Q4 2025, and -$14.3 million in Q3 2025.